Riik: Armeenia
keel: inglise
Allikas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
potassium chloride
Liqvor CJSC
A12BA01
potassium chloride
40mg/ml
solution for i/v infusion
200ml plastic pack
Prescription
Registered
2016-06-08
1 INSTRUCTION ON THE DRUG MEDICAL USE KALIUM CHLORIDE solution for infusion 4 % REGISTRATION NUMBER: COMMERCIAL TITLE: Kalium Chloride INTERNATIONAL NONPROPRIETARY NAME: Potassium chloride DOSAGE FORM: Solution for infusion 4 % COMPOSITION: _Active ingredient_ : potassium chloride – 4,0 g, _inactive ingredient_ : water for injection – up to 100 ml. DESCRIPTION: Clear, colorless solution. PHARMACOTHERAPEUTICAL GROUP – Potassium preparations CODE ATC: В05XА01 PHARMACOLOGICAL EFFECT _PHARMACODYNAMICS_ Potassium is the major ion of body cells, plays an important role in the regulation of various body functions. It is essential for maintenance of acid-base balance, isotonicity and electric membrane potential of cell. It is necessary for the conduction of nerve impulses and muscular contraction. The drug improves muscular contraction in muscular dystrophy and myasthenia. Potassium chloride is used as a source of potassium ions for prevent and recovery potassium deficiency in body. _PHARMACOKINETICS _ Potassium chloride is vell and quickly absorbed through the gastrointestinal tract; mainly excreted by the kidneys by secretion in the distal tubule, where also is exchange sodium- potassium ions. The ability of the kidneys to maintain potassium is insignificant, its urinary excretion is maintained even in significant decrease of potassium level in the body. Tubular secretion of potassium is influenced by chloride ion concentration, hydrogen ion exchange, acid-base balance, and adrenal hormones. A small amount of potassium excreted in faeces, and saliva, then with bile and pancreatic juice. 2 INDICATIONS Prevention and treatment of hypokalemia, caused by various reasons (use saluretics, increased potassium excretion by the kidneys, etc.); prevention of hypokalemia in patients with arrhythmias or patients taking digitalis preparations; intoxication with digitalis drugs. DOSAGE AND ADMINISTRATION _THE DRUG IS USED ONLY IN DILUTED FORM. _ Adults, children and elderly intravenously by infusion (20 - 30 drops per minute Lugege kogu dokumenti
CYMMA PI{Afl ,YAPA KTEPHCTHI{A JI E K.{PCTB E H HO TO NF E N A PATA (fiPC) KAJIltg xJroPHA pacrBop Arrn HH(l}y3Hrl 4 % 1. Konrmepqec*oe Har{MeHoBaHHe nperaparor: I(AJI!{JI Xnarsul Mex(AYHilpoAI{oe lraHI}IeHOBArrHe flKTr.rBHbrx Berrlecrn: potassiurl chloricle 2" KonuqesrBe*Hurfi H Kaqecr*er{Hbrfi cocran. Kalnn xfiopuAa - 4 , 0 r (Eur. Ph., monograph 0l g5) BoAr,l ,{nrr HnT'exuprfi - go 100 nrn (Eur. ph., rnonograph 0169) 3. sapnraue'Trqec*arr sopnra: pacrBop A,,rx nucfryrnfi 4 %. 4. KnllgurrccrcHe xapaKTepucrr{Kn 4.1, floma3aHltrr llpodllrnaKTI4Ka w rerleH,e rHnoKaJIHer\,rr{H, n':Bauuolyr pa3Jrr.rqFrbrMH npprr{HHaN{pr (npuertt ca^ryperl4KoB' noBbIIIIeHHoe BbIAerreHHe Karurr noqKaMpr vt r.,r.); npo{:unaKTl'tKil rHnoKaJIHEivI:HH y 6onrHux c apurncreii cepnua vfrw 6orurux, npl,fHl{Malorqnx npe[apaTbr HaIIepsTflFrKHl HHTOKC[rKar{Hfl npeflapaTal,rH Hanepc.TrHKH. 4.2. Pexr{rvt Ao3r{poBarrun Irpenapsr, ttct .oJtbgosflm.b mofi bto o pasfugsJre*How eude. Brpocnuiu, rlerf,h{ I{ no}KHTIhIM BHyrpprBeHHO KareJrLr{o (20 - 30 Kan. r uun.) Ao I ,5 r s 500 Mrl H3oroHpIr{ecKoro pacrnopa r{aTpr.rfl xnop}rra uns 5 oh pacrnopa rnror(o3br. {o:a ilpenapara 3aBr.rcHT oT rroxa3aTeJrfl coAep]Kanr.rlt r(aJr}{, B cbrBoporKe KpoBr{. [e dr H'{HT K a"yrr{Jr p aacq r{TbrB a}or no $ oprnryre : Itarlui (rrrnro.ur) * Bes rera (xr) x 0,2 x Z x 4,5 I ul npsnapara coAepxuT 0,52 Mruorrb r{aJrpr.fl. 4,5 - Hopri{B.rrbur,rrl ypoBeHb Ka.ilr.{fl B crbrBoporxg ('s N{Nrorb}, Marccunrturrlr-raJr cyT'orlHag Aora He Ao,[xna rrpeBlrrularb Te"rIa. llpn geo6xo,xprr\,tocTl.r Hcrrorrb3o*aH,n Bbrco*I4x .,{.g r.J AOJI)I.CFI IsBOAI,ITI}C'I C NOMOIIIbIO INH$Y:rrOHHOfO HACOCA. 4.3. flporuBoro Ka3aHHfl frnnepraJr,eJvrr.{fl, r'nepxJropeMprfl, Hapy[ueHHe anypneri. a3oT'einuel:r), 6oterHn AAflucoHa" cy/Iopofpr. 4.4. Oco6ue yKa3aI{Hff Kon4eun'puposfiH*btl-( pilcrnsop! Irpu+teil*mt] pttsfuuen€H*bt.,t s pucm.ape Harnpun .unopuda QrF % unu S yo znwKosw. llpenapar: neo6'\orl{i\'ro ITpHN{eH-srb Br{yTpr,rrJsr-rFro c ocropox(Hocrbm pf3-3a pl'rc*a pa:l'r.r'fr.r fr.Inep*aflHeM'.rfi. Lugege kogu dokumenti